Aubagio is used to prolong abilities of people with relapsing remitting MS
Aubagio, a drug used to prolong abilities of people with relapsing remitting MS, is now covered under the Yukon Government’s drug plan. (Mark Blinch/ Reuters)
The Yukon Government has decided to cover the cost of Aubagio, a pill used to treat symptoms of multiple sclerosis.
Aubagio prolongs the physical abilities of people with relapsing remitting multiple sclerosis, or RRMS.
The cost of the drug – about $1,500 per month – used to be an obstacle for some people, according to Jenny Roberts, president of the Yukon Multiple Sclerosis Association.
Roberts, who lives with RRMS, says the drug can have a significant impact on the nearly 200 residents of the territory living with multiple sclerosis. Aubagio reduces flare-ups of MS symptoms by as much as 30 per cent.
“If it slows down progression and disability to that percentage, than it means more people can stay in the workforce that much longer and live more of a healthy, normal lifestyle,” she says.
~~~~~~~~~~~~~~~~~~~~
.
.
.
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
